NCT03740906View on ClinicalTrials.gov

Direct-acting Antiviral Therapy and Reinfection Among People With Chronic Hepatitis C Virus Infection and Recent Injecting Drug Use in the Prison Setting

CompletedOBSERVATIONAL

Enrollment

202

Participants

Timeline

Start Date

September 6, 2019

Primary Completion Date

January 31, 2022

Study Completion Date

March 31, 2022

Conditions

Hepatitis C, Chronic

Trial Locations (1)

Unknown

NSW Correctional Centres, Sydney

Sponsors

Lead Sponsor

Kirby Institute

All Listed Sponsors

lead

Kirby Institute

OTHER_GOV

NCT03740906 - Direct-acting Antiviral Therapy and Reinfection Among People With Chronic Hepatitis C Virus Infection and Recent Injecting Drug Use in the Prison Setting | Biotech Hunter | Biotech Hunter